Tuesday - July 8, 2025
SOMERSET, N.J., June 20, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today that Hadi Chaudhry, CareCloud president and chief executive officer, and Bill Korn, chief strategy officer and acting chief financial officer, will be representing the company in two fireside chats on Thursday, June 22, 2023. The purpose of these discussions is to explore the transformative power of generative artificial intelligence in the healthcare industry.
To register for these events or to learn more about upcoming events, please visit CareCloud's investor relations site, ir.carecloud.com/news-events/ir-calendar.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
SOURCE CareCloud
Company Contact:
Bill Korn
Chief Strategy Officer
CareCloud
bkorn@carecloud.com
Investor Contact:
Asher Dewhurst
ICR Westwicke
CareCloudIR@westwicke.com
Media Inquiries:
Alexis Feinberg
ICR Westwicke
CareCloudPR@westwicke.com
Last Trade: | US$2.36 |
Daily Change: | -0.10 -4.07 |
Daily Volume: | 542,467 |
Market Cap: | US$38.370M |
June 02, 2025 May 06, 2025 April 07, 2025 April 02, 2025 March 26, 2025 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load